UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (right to buy) | Â (1) | 12/31/2025 | Common Stock | 75,000 | $ 11.87 | D | Â |
Employee Stock Option (right to buy) | Â (2) | 01/08/2026 | Common Stock | 5,890 | $ 9.09 | D | Â |
Employee Stock Option (right to buy) | Â (3) | 01/03/2027 | Common Stock | 37,500 | $ 2.97 | D | Â |
Employee Stock Option (right to buy) | Â (4) | 01/04/2028 | Common Stock | 37,500 | $ 9.3 | D | Â |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Wise Bart W C/O DICERNA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE CAMBRIDGE, MA 02140 |
 |  |  SVP, Legal Affairs |  |
/s/ John B. Green, attorney-in-fact | 06/26/2018 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | This option vested 25% on October 6, 2016, and the remaining 75% vests in 36 monthly installments thereafter, subject in each case to the reporting person's continued service with the issuer through the applicable vesting date. |
(2) | The option vests in 48 monthly installments over the four-year period which commenced on the last day of January 2016, subject in each case to the reporting person's continued service with the issuer through the applicable vesting date. |
(3) | The option vests in 48 monthly installments over the four-year period which commenced on the last day of January 2017, subject in each case to the reporting person's continued service with the issuer through the applicable vesting date. |
(4) | The option vests in 48 monthly installments over the four-year period which commenced on the last day of January 2018, subject in each case to the reporting person's continued service with the issuer through the applicable vesting date. |
 Remarks: Exhibit 24 - Power of Attorney |